PRPF8 and cancer: Remarkably, while normal cells seem to tolerate a reduction in the activity of PRPF8 or other spliceosome components8,15, cancer cells seem to be highly sensitive to a reduction in spliceosome activity, paving the way for targeting the splicing machinery to develop novel strategies for the management and treatment of HCC.